Stoke Therapeutics Inc
Ownership
Ownership Structure
Who owns Stoke Therapeutics Inc (STOK)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 76.3% of the shares are freely tradable; institutional investors hold 120.3%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| RTW INVESTMENTS, LLC | 8.72 | 5,623,525 | +1.4 | 03/31/2026 |
| BlackRock Inc | 8.35 | 5,385,714 | +3.3 | 03/31/2026 |
| FMR Inc | 8.34 | 5,383,666 | -3.9 | 03/31/2026 |
| Lynx1 Capital Management, LP | 6.26 | 4,038,404 | -15.2 | 06/30/2026 |
| Redmile Group, LLC | 6.12 | 3,945,920 | -5.2 | 06/30/2026 |
| Wellington Management Company LLP | 5.45 | 3,519,301 | +13.7 | 06/30/2026 |
| Morgan Stanley - Brokerage Accounts | 5.31 | 3,423,280 | -3.5 | 03/31/2026 |
| Baker Bros Advisors LP | 5.17 | 3,336,697 | +0.0 | 03/31/2026 |
| The Toronto-Dominion Bank | 4.92 | 3,173,258 | +0.0 | 03/31/2026 |
| Bvf Inc | 3.95 | 2,547,557 | +12.4 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Kaye Edward M. MD | Director | 124,557 | 3,599,697 $ | Aug 18, 2026 | direct |
| Allan Jonathan | GENERAL COUNSEL & CORP SEC | 21,225 | 613,403 $ | Aug 18, 2026 | direct |
| Ticho Barry | CHIEF MEDICAL OFFICER | 20,110 | 581,179 $ | Sep 1, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 1,600 | 31.06 | 49,691 |
| Sep 1, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 3,945 | 30.51 | 120,370 |
| Aug 18, 2026 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sell | 145 | 32.47 | 4,708 |
| Aug 18, 2026 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sell | 2,716 | 32.01 | 86,932 |
| Aug 18, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 242 | 32.47 | 7,857 |
| Aug 18, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 4,525 | 32.01 | 144,833 |
| Aug 18, 2026 | Kaye Edward M. MD | Director | Sell | 637 | 32.47 | 20,682 |
| Aug 18, 2026 | Kaye Edward M. MD | Director | Sell | 11,930 | 32.01 | 381,846 |
| Aug 14, 2026 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Other | 6,000 | 0.00 | – |
| Aug 14, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | Other | 10,000 | 0.00 | – |
| Aug 14, 2026 | Kaye Edward M. MD | Director | Other | 26,250 | 0.00 | – |
| Aug 3, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 1,269 | 29.45 | 37,377 |
| Aug 3, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 5,907 | 28.95 | 171,008 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.